CNX Therapeutics

London, United Kingdom Founded: 2021 • Age: 5 yrs
Distributor of specialty drugs
Request Access

About CNX Therapeutics

CNX Therapeutics is a company based in London (United Kingdom) founded in 2021.. CNX Therapeutics has completed 1 acquisition, including Synchrony Pharma. CNX Therapeutics operates in a competitive market with competitors including Cardinal Health, Concordia International, Xiel, Bartec Technologies and SPL Pharma, among others.

  • Headquarter London, United Kingdom
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name Cnx Therapeutics Limited
  • Date of Incorporation 01 May, 1997
  • Jurisdiction LONDON, ENGLAND
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of CNX Therapeutics
Headcount 10-50
Employee Profiles 15
Employee Profiles
People
Matthew Barker
Vice President, Transformation & Strategy
People
Miguel Sabariego
Senior Business Development Manager
People
Dr Benjamin Moore
Vice President Corporate Development
People
Sarah Morbey
Vice President, Legal & ESG

Unlock access to complete

Funding Insights of CNX Therapeutics

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by CNX Therapeutics

CNX Therapeutics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Synchrony Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Generic drugs are manufactured by Synchrony Pharma in the UK.
2008
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - CNX Therapeutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cnx Therapeutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of CNX Therapeutics

CNX Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cardinal Health, Concordia International, Xiel, Bartec Technologies and SPL Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple healthcare products and services are provided to organizations.
domain founded_year HQ Location
Distributes specialty pharmaceutical drugs to healthcare providers.
domain founded_year HQ Location
Specialist nuclear medicine and radiotherapy solutions are distributed.
domain founded_year HQ Location
Mediso: Advanced medical imaging systems and radioactive sources
domain founded_year HQ Location
International distribution of specialty medicines and pharmaceutical market access services.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cnx Therapeutics

Frequently Asked Questions about CNX Therapeutics

When was CNX Therapeutics founded?

CNX Therapeutics was founded in 2021.

Where is CNX Therapeutics located?

CNX Therapeutics is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

What does CNX Therapeutics do?

CNX Therapeutics was founded in 2021 and is based in London, United Kingdom. Operations are centered on the distribution of specialty drugs within the pharmaceutical sector. Therapeutic products are supplied to healthcare providers and institutions across the region. The companys domain, cnx-therapeutics.com, supports its online activities. Focus is placed on efficient logistics and regulatory compliance in drug handling. (62 words).

Who are the top competitors of CNX Therapeutics?

CNX Therapeutics's top competitors include Cardinal Health, Xiel and Bartec Technologies.

How many acquisitions has CNX Therapeutics made?

CNX Therapeutics has made 1 acquisition, including Synchrony Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available